Omnicell (OMCL) Misses Q3 EPS by 1c

Omnicell Achieves Record Revenue in the Third Quarter 2016

MOUNTAIN VIEW, Calif., Oct. 27, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2016. 

GAAP results: Revenue for the third quarter of 2016 was $176.7 million, up $3.8 million, or 2.2% from the second quarter of 2016, and up $51.5 million or 41.1% from the third quarter of 2015. Revenue for the nine months ended September 30, 2016 was $520.6 million, up $166.4 million or 47.0% from the nine months ended September 30, 2015.

Third quarter... More

Wellforce Selects Omnicell's Medication Management Automation and Diversion Prevention Solutions

MOUNTAIN VIEW, Calif., Oct. 27, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Wellforce has selected the Company's medication management automation and analytics solutions to ensure medication security and safety at its hospitals. Wellforce, a health system founded in 2014 by Massachusetts-based Tufts Medical Center and Lowell General Hospital, is committed to innovation and leveraging new technologies to further improve patient safety while maintaining lower healthcare costs.... More

Leading Academic Medical Centers Upgrade Medication Management Technology to Increase Patient Safety and Promote Innovation

MOUNTAIN VIEW, Calif., Oct. 26, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced a partnership with two prestigious academic medical centers to enhance clinical staff workflows and foster improved patient care. Both Dartmouth-Hitchcock (Lebanon, N.H.) and Stanford Health Care (Palo Alto, Calif.) are deploying the Company's solutions to upgrade medication management technology to optimize patient outcomes.

Academic medical centers play a leadership role in improving the standards of medication delivery and patient care to ensure the healthiest,... More